IL17A and Crohn disease: Based on the similarity between NEC and Crohn's disease [11], one may speculate that as proposed for Crohn's disease [36], the development of specific inhibitors for IL-17F could become a potential option for treating NEC although it is important to consider that other organs such as the lung or the brain could also be affected by IL-17 blockade [37, 38].